The Effects of Sedatives on Tobacco Use Disorder
Brief Summary
This proposal will obtain preliminary data on the effect of a single sub-anesthetic dose of a sedative on cigarette craving and smoking behavior as well as measuring tolerability and acceptability.
Intervention / Treatment
-
Drug: midazolam intravenous infusion
-
Drug: placebo intravenous infusion
-
Drug: Ketamine Intravenous Infusion
Condition or Disease
- Tobacco Use Disorder
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Recruiting |
| Study results: | No Results Available |
| Age: | 18 Years to 55 Years (Adult) |
| Enrollment: | 20 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Jun 01, 2019 | |
|---|---|---|
| Primary Completion: | May 31, 2021 | |
| Completion Date: | May 31, 2021 | |
| Study First Posted: | Jan 23, 2019 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Jul 21, 2020 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 55 |
This clinical trial is recruiting
Are you interested in participating in this trial or others? We'd love to help.
More Details
| NCT Number: | NCT03813121 |
|---|---|
| Acronym: | SED-TUD |
| Other IDs: | 229077 |
| Study URL: | https://ClinicalTrials.gov/show/NCT03813121 |
Last updated: Jan 27, 2021